Maple Syrup Urine Disease (MSUD) is a rare autosomal recessive inborn error of metabolism caused by deficiency of the branched-chain α-ketoacid dehydrogenase (BCKD) complex. This leads to accumulation of the branched-chain amino acids leucine, isoleucine, and valine and their toxic metabolites. The hallmark is a sweet “maple syrup” odour of urine and earwax, alongside rapidly progressive neurotoxicity.

🧠 Pathophysiology (Exam Gold)

🧪 Defective breakdown of branched-chain amino acids (BCAAs)
⬆️ Accumulation of leucine (most neurotoxic)
🧠 Leucine disrupts brain metabolism → cerebral oedema, encephalopathy
🔋 Impaired energy metabolism contributes to neuronal injury

⚠️ Clinical Presentation

👶 Typically presents in the first week of life
🍼 Initially well → then poor feeding, vomiting
🧠 Lethargy → irritability → seizures → coma
👃 Characteristic sweet smell (burnt sugar / maple syrup)
⚡ Abnormal tone (hypotonia or hypertonia)

🚨 Acute Deterioration

📉 Rapid neurological decline
🧠 Risk of cerebral oedema and death if untreated
⚠️ Often mistaken for neonatal sepsis

🧪 Investigations

🧬 Plasma amino acids – markedly ↑ leucine, isoleucine, valine
🧪 Urine organic acids – branched-chain ketoacids
🧴 Newborn screening (UK) – detects elevated leucine
🧫 May show metabolic acidosis

💊 Management

🚫 Stop protein intake immediately
🍬 Give high-dose IV glucose ± insulin to reduce catabolism
🧪 Rapid reduction of leucine levels (specialist formulas)
💧 IV fluids and electrolyte correction
⚠️ Severe cases → dialysis to remove toxic metabolites
📞 Urgent involvement of metabolic specialists

🥗 Long-Term Management

🍽️ Lifelong dietary restriction of branched-chain amino acids
🧪 Regular monitoring of amino acid levels
💊 Thiamine supplementation (some variants are responsive)
⚠️ Avoid catabolic stress (illness, fasting)

🧠 Variants

⚡ Classic MSUD – severe, neonatal onset
⏳ Intermediate / intermittent forms – later, milder presentations
💊 Thiamine-responsive – partial enzyme activity

👶 Newborn Screening (UK Context)

🧪 Included in heel prick test (day 5)
🎯 Early detection allows pre-symptomatic treatment
🧠 Prevents severe neurological damage

💡 Exam & Clinical Tips

🍁 Sweet-smelling urine = MSUD until proven otherwise
🧠 Leucine is the main driver of neurotoxicity
⚠️ Think MSUD in a neonate with encephalopathy + normal infection screen
🚫 Never delay treatment while waiting for confirmation
📉 Early treatment dramatically improves outcomes

From a clinical reasoning perspective, MSUD is a classic example of toxic metabolite accumulation. Leucine crosses the blood–brain barrier and disrupts neurotransmitter synthesis and cerebral energy metabolism, leading to rapid neurological deterioration. The neonatal period is particularly vulnerable because feeding introduces protein load that the defective pathway cannot handle. In UK practice, early recognition via newborn screening and aggressive metabolic management is essential, as delays can result in irreversible brain injury or death.

The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms.

Maple Syrup Urine disease